Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.00
Bid: 4.00
Ask: 6.00
Change: 0.00 (0.00%)
Spread: 2.00 (50.00%)
Open: 5.00
High: 5.00
Low: 5.00
Prev. Close: 5.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

20 Apr 2015 07:00

RNS Number : 6237K
Braveheart Investment Group plc
20 April 2015
 



20 April 2015

 

Braveheart Investment Group plc

 

Directorate change

 

Braveheart Investment Group plc (AIM: BRH), the financial services company that facilitates SME growth through investment by public and private sector sources, today announces that following a review of its management structure and cost base, the Company has identified a number of synergies and cost savings which will enable it to reduce ongoing operating costs by combining certain functions.

 

As a result Aileen Brown has stepped down as Chief Financial Officer. Her role will be assumed by the two other, non-board members of the accounts team, being Jennifer Kennedy ACCA (financial controller) and Kevin Brown (company accountant) who have been with the Company for an aggregate of 13 years. Geoffrey Thomson, Chief Executive Officer, will take overall responsibility for oversight of the accounting function. Kevin Brown is taking up the role of Company Secretary. These changes are effective as of today's date.

 

As previously announced in the Company's interim results, Ken Brown, non-executive director, stepped down on 31 March having served for seven and a half years.

 

The Board would like to thank those standing down for their hard work and commitment over the years.

 

 

For further information please visit www.braveheartinvestmentgroup.co.uk or contact:

 

Braveheart Investment Group plc

Geoffrey Thomson, Chief Executive

gthomson@braveheartgroup.co.uk

Tel: +44 1738 587555

 

Sanlam Securities UK Limited (Nominated Advisor and Broker to Braveheart)

Lindsay Mair

Tel: +44 20 7628 2200

 

Media Enquiries:

Allerton Communications

Peter Curtain

peter.curtain@allertoncomms.co.uk

Tel: +44 20 3137 2500

 

Notes to Editors:

Braveheart Investment Group provides a range of products and services to investors seeking exposure to SME investments. Our clients include high-net-worth individuals looking to build tax-efficient Enterprise Investment Scheme (EIS) and Seed EIS portfolios, public-sector organisations, family offices and other institutions. Products available range from self-build portfolios to a full fund management service.

 

Funds managed by Braveheart and its subsidiaries/associate companies include: the Crowdcube Venture Fund, the Finance Yorkshire Equity Fund, the NI Growth Loan Fund, the Lachesis Fund, the Strathclyde Innovation Fund, the Viking Growth Fund and the Viking Loan Fund. Our operating companies are Strathtay Ventures, Viking Fund Managers and, partnering with NEL Fund Managers and Clarendon Fund Managers, WhiteRock Capital Partners LLP.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGUPPCUPAGAM
Date   Source Headline
5th Nov 20204:41 pmRNSSecond Price Monitoring Extn
5th Nov 20204:36 pmRNSPrice Monitoring Extension
4th Nov 20208:52 amRNSExercise of Warrants and Issue of Equity
3rd Nov 202011:06 amRNSSecond Price Monitoring Extn
3rd Nov 202011:00 amRNSPrice Monitoring Extension
2nd Nov 20202:06 pmRNSSecond Price Monitoring Extn
2nd Nov 20202:01 pmRNSPrice Monitoring Extension
29th Oct 20204:40 pmRNSSecond Price Monitoring Extn
29th Oct 20204:35 pmRNSPrice Monitoring Extension
29th Oct 20207:00 amRNSIssue of shares to certain directors and TVR
27th Oct 20202:05 pmRNSSecond Price Monitoring Extn
27th Oct 20202:00 pmRNSPrice Monitoring Extension
23rd Oct 20207:00 amRNSUpdate on Pharm2Farm’s COVID-19 mask project
19th Oct 20202:06 pmRNSSecond Price Monitoring Extn
19th Oct 20202:00 pmRNSPrice Monitoring Extension
19th Oct 202012:42 pmRNSFurther re. Conditional Sale of Pharm2Farm holding
19th Oct 202012:35 pmRNSPublication of Circular and Notice of GM
16th Oct 20207:00 amRNSFurther update re Paraytec Limited
8th Oct 20204:09 pmRNSUpdate on Pharm2Farm
5th Oct 202011:20 amRNSFurther update re Paraytec Limited
29th Sep 20204:40 pmRNSSecond Price Monitoring Extn
29th Sep 20204:35 pmRNSPrice Monitoring Extension
24th Sep 20207:00 amRNSUpdate on Phasefocus Holdings Limited
18th Sep 20207:00 amRNSUpdate on the Pharm2Farm anti-viral mask project
8th Sep 202012:18 pmRNSResult of AGM
3rd Sep 20207:00 amRNSFurther re Paraytec Limited
28th Aug 20205:00 pmRNSTotal Voting Rights
21st Aug 20205:09 pmRNSConditional Sale of Pharm 2 Farm Limited holding
20th Aug 20201:04 pmRNSHolding(s) in Company
5th Aug 20204:41 pmRNSSecond Price Monitoring Extn
5th Aug 20204:35 pmRNSPrice Monitoring Extension
5th Aug 20207:00 amRNSFurther re Paraytec Limited
4th Aug 20207:00 amRNSFinal Results
23rd Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 20204:41 pmRNSSecond Price Monitoring Extn
21st Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20207:18 amRNSParticipation in RMS placing
7th Jul 20207:00 amRNSFurther re Paraytec Limited
1st Jul 20202:31 pmRNSHolding(s) in Company
30th Jun 20205:00 pmRNSTotal Voting Rights
30th Jun 20203:00 pmRNSAcquisition of 18.1% interest in RMS
19th Jun 20202:29 pmRNSOperational Update
9th Jun 20207:00 amRNSFurther re Paraytec Limited
8th Jun 20207:00 amRNSHolding(s) in Company
5th Jun 202012:44 pmRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNSAcquisition of Additional PhaseFocus Shares
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
3rd Jun 20207:00 amRNSDirector/PDMR Shareholding
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.